{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T05:54:47Z","timestamp":1772603687440,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1983,1,1]],"date-time":"1983-01-01T00:00:00Z","timestamp":410227200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[1983]]},"DOI":"10.1007\/bf00516553","type":"journal-article","created":{"date-parts":[[2004,11,18]],"date-time":"2004-11-18T06:27:30Z","timestamp":1100759250000},"page":"41-44","source":"Crossref","is-referenced-by-count":81,"title":["Cutaneous histamine levels and histamine releasability from the skin in atopic dermatitis and hyper-IgE-syndrome"],"prefix":"10.1007","volume":"275","author":[{"given":"Thomas","family":"Ruzicka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Gl\ufffdck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0009-8981(72)90419-6","volume":"37","author":"MA Beaven","year":"1972","unstructured":"Beaven MA, Jacobsen S, Horakova Z (1972) Modification of the enzymatic isotopic assay of histamine and its application to measurements of histamine in tissues, serum and urine. Clin Chim Acta 37:91?103","journal-title":"Clin Chim Acta"},{"key":"CR2","volume-title":"Handbook of experimental pharmacology, vol XVIII\/1","author":"SE Lindell","year":"1966","unstructured":"Lindell SE, Westling H (1966) Histamine metabolism in man. In: Roche a Silva (ed) Handbook of experimental pharmacology, vol XVIII\/1. Springer, Berlin Heidelberg. New York"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/1523-1747.ep12544308","volume":"71","author":"LM Lichtenstein","year":"1978","unstructured":"Lichtenstein LM, Marone G, Thomas LT, Malveaux FJ (1978) The role of basophils in inflammatory reactions. J Invest Dermatol 71:65?69","journal-title":"J Invest Dermatol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000232264","volume":"59","author":"J Ring","year":"1979","unstructured":"Ring J (1979) Atopic dermatitis: a disease of general vasoactive mediator dysregulation. Int Arch Allergy Appl Immunol 59:233?239","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000232208","volume":"58","author":"J Ring","year":"1979","unstructured":"Ring J, O'Connor R (1979) In vitro histamine and serotonin release studies in atopic dermatitis. Int Arch Allergy Appl Immunol 58:322?330","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"CR6","first-page":"295","volume":"24","author":"W Kazimierczak","year":"1978","unstructured":"Kazimierczak W, Diamant B (1978) Mechanisms of histamine release in anaphylactic and anaphylactoid reactions. Prog Allergy 24:295?330","journal-title":"Prog Allergy"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1084\/jem.136.3.556","volume":"136","author":"M Kaliner","year":"1972","unstructured":"Kaliner M, Orange RP, Austen KF (1972) Immunological release of histamine and SRS-A from human lung. IV. Enhancement by cholinergic and ?-adrenergic stimulation. J Exp Med 136:556?567","journal-title":"J Exp Med"},{"key":"CR8","first-page":"831","volume":"19","author":"LM Lichtenstein","year":"1970","unstructured":"Lichtenstein LM, Levy DA, Ishizaka K (1970) In vitro reversed anaphylaxis: characteristics of anti-IgE mediated histamine release. Immunology 19:831?842","journal-title":"Immunology"},{"key":"CR9","first-page":"499","volume":"6","author":"WDM Paton","year":"1951","unstructured":"Paton WDM (1951) Compound 48\/80: a potent histamine liberator. Br J Pharmacol 6:499","journal-title":"Br J Pharmacol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1476-5381.1979.tb07871.x","volume":"65","author":"LG Garland","year":"1979","unstructured":"Garland LG, Payne AN (1979) Role of cell-fixed Ca++ in histamine release by compound 48\/80. Br J Pharmacol 65:609?613","journal-title":"Br J Pharmacol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1542\/peds.49.1.59","volume":"49","author":"RH Buckley","year":"1972","unstructured":"Buckley RH, Wray BB, Belmaker EZ (1972) Extreme hyper-immunoglobulinemia E and undue susceptibility to infection. Pediatrics 49:59?70","journal-title":"Pediatrics"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1476-5381.1977.tb07538.x","volume":"60","author":"D Francis","year":"1977","unstructured":"Francis D, Greaves MW, Yamamoto S (1977) Enzymatic histamine degradation by human skin. Br J Pharmacol 60:583?587","journal-title":"Br J Pharmacol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough HJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265?275","journal-title":"J Biol Chem"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/jid.1960.38","volume":"34","author":"HH Johnson","year":"1960","unstructured":"Johnson HH, de Oreo G, Lascheid WP, Mitchell F (1960) Skin histamine levels in chronic atopic dermatitis. J Invest Dermatol 34:237?238","journal-title":"J Invest Dermatol"},{"key":"CR15","first-page":"383","volume":"47","author":"L Juhlin","year":"1967","unstructured":"Juhlin L (1967) Localisation and content of histamine in normal and diseased skin. Acta Derm Venereol (Stockh) 47:383?391","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0021-8707(66)90069-4","volume":"38","author":"MB Cole","year":"1966","unstructured":"Cole MB, Roberts FE (1966) Inflammatory response to histamine in atopic and nonatopic individuals. J Allergy 38:26?30","journal-title":"J Allergy"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/j.1365-3083.1977.tb00361.x","volume":"6","author":"I-L Strannegard","year":"1977","unstructured":"Strannegard I-L, Strannegard \ufffd (1977) Increased sensitivity of lymphocytes from atopic individuals to histamine-induced suppression. Scand J Immunol 6:1225?1231","journal-title":"Scand J Immunol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0091-6749(77)90161-0","volume":"59","author":"H Verhaegen","year":"1977","unstructured":"Verhaegen H, de Docke W, de Cock J (1977) Histaminereceptor-bearing peripheral T lymphocytes in patients with allergies. J Allergy Clin Immunol 59:266?268","journal-title":"J Allergy Clin Immunol"},{"key":"CR19","first-page":"R54","volume":"311","author":"S Gl\ufffdck","year":"1980","unstructured":"Gl\ufffdck S, Staubach V, Schmutzler W (1980) Further studies on the nature of the cholinergic histamine release from mast cells. Naunyn-Schmiedebergs Arch Pharmacol 311:R54, 215","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF01964880","volume":"7","author":"FL Pearce","year":"1977","unstructured":"Pearce FL, Behrendt H, Blum U, Poblete-Freundt G, Pult P, Stang-Voss C, Schmutzler W (1977) Isolation and study of functional mast cells from lung and mesentery of the guinea pig. Agents Actions 7:45?56","journal-title":"Agents Actions"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"679","DOI":"10.4049\/jimmunol.118.2.679","volume":"118","author":"WA Hook","year":"1977","unstructured":"Hook WA, Siraganian RB (1977) Complement-induced histamine release from human basophils. III. Effect of pharmacologic agnets. J Immunol 118:679?684","journal-title":"J Immunol"},{"key":"CR22","first-page":"658","volume":"200","author":"RH Hino","year":"1977","unstructured":"Hino RH, Lau CKH, Read GW (1977) The site of action of the histamine releaser compound 48\/80 in causing mast cell degranulation. J Pharmacol Exp Ther 200:658?663","journal-title":"J Pharmacol Exp Ther"},{"key":"CR23","first-page":"185","volume":"42","author":"R Voorhorst","year":"1979","unstructured":"Voorhorst R, van den Hooft van Asbeck MC (1979) Atopic skin test re-evaluated: VI. Skin reactions to compound 48\/80 and histamine in patients with atopic and non-atopic chronic respiratory complaints and in normal volunteers. Ann Allergy 42:185?186","journal-title":"Ann Allergy"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00516553.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00516553\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00516553","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T09:20:59Z","timestamp":1682846459000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00516553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1983]]}},"alternative-id":["BF00516553"],"URL":"https:\/\/doi.org\/10.1007\/bf00516553","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1983]]}}}